학술논문

Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet
Document Type
Article
Source
In: Diabetes, Obesity and Metabolism. (Diabetes, Obesity and Metabolism, 2009, 11(9):865-873)
Subject
Language
English
ISSN
14631326
14628902